ABOUT LOCATIONS CAREERS NEWS DOWNLOADS CONTACT EN DE ES PRODUCTS SERVICES TECHNOLOGIES INNOVATION Global provider of respiratory drug-delivery devices and components to the pharmaceutical sector H&T Presspart is a world leader and specialist in manufacturing drug-delivery systems and pharmaceutical components. The solutions we offer our pharmaceutical clients include metered-dose inhaler canisters and components, and a comprehensive range of dose-counting technologies. We offer more than 45 years’ experience of meeting the needs of the world’s leading pharma companies. During that time we’ve developed a strong reputation for precision and reliability, critically important when patients’ quality of life can depend on the tiniest of details, both in the medication and its delivery system. Our extensive skills and experience as drug delivery component manufacturers cover every aspect of deep-drawn manufacturing and injection moulding for the pharmaceutical industry. As healthcare and pharmaceutical knowledge and understanding continue to evolve, so do we. We focus on industry-leading innovations, continually pushing the boundaries to find technologies that will improve drug delivery performance for our customers and their patients. You can use our advice, support and experience to help you make the best decisions early in the product and device development process. Plasma H&T Presspart offers a revolutionary sub-micron plasma technology process- manufactured under license from Portal Medical- for treating the internal surface of metered-dose inhaler canisters. The plasma treatment process improves the surface energy properties of an MDI canister, thus helping to prevent the active content of a drug formulation adhering to the canister wall. DISCOVER MORE Quantum Our off-the-shelf Quantum ™® dose indicator is the very first on-can end-of-life solution, ensuring patients don’t run out of their medication. It’s cost-effective, disposable, and simple to use – and, as it includes no mechanical parts, it’s extremely reliable. DISCOVER MORE eMDI H&T Presspart and Cohero Health have developed the first market-ready, fully embedded and connected metered-dose inhaler (MDI). By tracking and recording data on the use of medications, and sharing it with patients and physicians via a mobile or web app, the eMDI ™ enables pharmaceutical manufacturers to bring the best possible care to those with asthma and COPD. DISCOVER MORE Mechanical Dose Counter Asthma and COPD are conditions that need constant monitoring and controlling. So methods for predicting the end of life of metered-dose inhalers can improve patient safety and quality of life, as well as reduce hospital admissions. DISCOVER MORE Can-in-can With H&T Presspart’s Can in Can, you can have metered-dose inhaler (MDI) canisters with smaller fill volumes, without changing the outer shell – ideal for sample products and line extensions. DISCOVER MORE PowdAir Plus In developing markets, where demand for respiratory treatments is growing rapidly, there’s an increasing need to offer more choice to patients who use a dry powder inhaler (DPI). DISCOVER MORE In 2016, we manufactured over 900 million MDI cans, actuators assembled devices and plastic components. We employ over 400 employees across our three European sites, UK, Germany & Spain. Over EUR 8 million invested in product development, manufacturing capabilities and capacities in 2014. Deep-drawn manufacturing process for MDI cans OUR STATE OF THE ART FACILITIES Our three European manufacturing sites produce over 75% of the world’s metered-dose inhaler components. Our facilities also include the brand new state of the art Inhalation Product Technology Centre (IPTC). DISCOVER MORE PowdAir Plus Dry Powder Inhaler OUR INNOVATION H&T Presspart is at the cutting edge of drug delivery component design and manufacture. The drug delivery components we help to create are some of the most innovative & reliable on the market. We strive to stay ahead of the changes within the pharmaceutical market to ensure we are always able to offer the right solution for your needs. DISCOVER MORE OUR PARTNERS Our partners are the world leaders within the pharmaceutical industry for respiratory drug delivery solutions. Our proven knowledge and expertise in the drug delivery market makes us the partner of choice for the industry. DISCOVER MORE OUR LOCATIONS H&T Presspart has three European manufacturing sites in the UK, Germany & Spain. Committed to supporting our regional customers, H&T Presspart also has sales office based in Singapore, India, Uruguay & the USA. DISCOVER MORE OUR TALENT As a market leader in our field, H&T Presspart employees people from a wide range of career and skill backgrounds. H&T Presspart invests heavily in the training and education of employees with major specialised training programmes, including a long-established Apprenticeship scheme DISCOVER MORE OUR PRODUCTS H&T Presspart & Cohero Health have developed the first market ready connected metered-dose inhaler. Presspart will be showcasing this @DDLConferences so if you have any questions then please come & see us at stand 122. #innovation #eMDI #PowdAirPlus presspart.com/products/emdi/ 15 hours ago Asthma & COPD are conditions that need constant monitoring & controlling. Methods for predicting the end of life of MDIs can improve patient safety & quality of life. @Presspart offers counters & indicators to address customer & market needs. #DDL2018 presspart.com/products/mdi-c… 22 hours ago In just a weeks time, @Presspart will be appearing at the 28th DDL exhibition in Edinburgh. For more information or to arrange a meeting during DDL, please contact us. #DDL2018 #Presspart presspart.com/contact/ 2 days ago Want to learn more about drug delivery to the lungs? H&T Presspart will be showcasing a strong range of respiratory drug delivery components @DDLConferences. #plasma #dosecounters #PowdAirPlus #eMDI #DDL2018 presspart.com/products/ 3 days ago With 8 days to go until @DDLConferences, final preparations are currently underway @Presspart. Be sure to come and say hello to the team located on stand 122 when you arrive next week. #DDL2018 presspart.com/ddl-28/ 3 days ago The @Presspart team collecting the award for 'Most Impact on Healthcare Community' at the GSK sponsored AIPIA World Congress Challenge 2018. pic.twitter.com/tiUcOfFupq 4 days ago We are extremely pleased that our connected device technology won the award for 'Most Impact on Healthcare Community' at the GSK sponsored AIPIA World Conference Challenge. Read all about it on our website. presspart.com/aipia-winners/ 2 weeks ago Here is Benjamin Jung presenting his winning pitch at this years GlaxoSmithKline (GSK) sponsored 2018 AIPIA World Congress Challenge. The team won the award for 'Most Impact on the health community' for our eMDI smart inhaler technology. #connectedhealth #mdi #smartinhaler pic.twitter.com/uipCoqz3W4 2 weeks ago Explore About H&T Presspart Locations Careers News Contact Latest News H&T Presspart wins award at 2018 GSK AIPIA World Congress Challenge READ MORE H&T Presspart participates in 2018 GSK AIPIA World Congress Challenge READ MORE H&T Presspart gains membership of The PCHAlliance READ MORE © 2018 Copyright H&T Presspart Manufacturing Ltd. All Rights Reserved. Privacy Policy | Privacy Settings | Terms & Conditions of Sale | Imprint | Website by Parker Design